Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 11137998)

1.

A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes.

Liu HX, Cartegni L, Zhang MQ, Krainer AR.

Nat Genet. 2001 Jan;27(1):55-8.

PMID:
11137998
2.

Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Cartegni L, Chew SL, Krainer AR.

Nat Rev Genet. 2002 Apr;3(4):285-98. Review.

PMID:
11967553
3.

The association of nonsense codons with exon skipping.

Valentine CR.

Mutat Res. 1998 Sep;411(2):87-117. Review.

PMID:
9806422
4.

Integration of splicing, transport and translation to achieve mRNA quality control by the nonsense-mediated decay pathway.

Schell T, Kulozik AE, Hentze MW.

Genome Biol. 2002;3(3):REVIEWS1006. Epub 2002 Feb 26. Review.

5.

The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision?

Silva AL, Romão L.

FEBS Lett. 2009 Feb 4;583(3):499-505. doi: 10.1016/j.febslet.2008.12.058. Epub 2009 Jan 20. Review.

6.

Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells.

Lejeune F, Maquat LE.

Curr Opin Cell Biol. 2005 Jun;17(3):309-15. Review.

PMID:
15901502
7.

[Progress on cis-acting regulatory elements in nonsense-mediated mRNA decay].

Huang Z, Zhou TH, Guo BJ.

Yi Chuan Xue Bao. 2004 Nov;31(11):1321-6. Review. Chinese.

PMID:
15651687
8.

Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges.

Kuzmiak HA, Maquat LE.

Trends Mol Med. 2006 Jul;12(7):306-16. Epub 2006 Jun 16. Review.

PMID:
16782405
9.

New insights into the formation of active nonsense-mediated decay complexes.

Singh G, Lykke-Andersen J.

Trends Biochem Sci. 2003 Sep;28(9):464-6. Review.

PMID:
13678954
10.

Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.

Maquat LE.

Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99. Review.

PMID:
15040442
11.

Introducing sense into nonsense in treatments of human genetic diseases.

Linde L, Kerem B.

Trends Genet. 2008 Nov;24(11):552-63. doi: 10.1016/j.tig.2008.08.010. Epub 2008 Oct 18. Review.

PMID:
18937996
12.

Bioinformatics and mutations leading to exon skipping.

Desmet FO, Béroud C.

Methods Mol Biol. 2012;867:17-35. doi: 10.1007/978-1-61779-767-5_2. Review.

PMID:
22454052
14.

Alternative splicing: good and bad effects of translationally silent substitutions.

Raponi M, Baralle D.

FEBS J. 2010 Feb;277(4):836-40. doi: 10.1111/j.1742-4658.2009.07519.x. Epub 2010 Jan 15. Review.

PMID:
20082637
15.

Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases.

Keeling KM, Bedwell DM.

Wiley Interdiscip Rev RNA. 2011 Nov-Dec;2(6):837-52. doi: 10.1002/wrna.95. Epub 2011 Jul 6. Review.

16.

Biomedical impact of splicing mutations revealed through exome sequencing.

Taneri B, Asilmaz E, Gaasterland T.

Mol Med. 2012 Mar 30;18:314-9. doi: 10.2119/molmed.2011.00126. Review.

17.

Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development.

Rowe SM, Clancy JP.

BioDrugs. 2009;23(3):165-74. doi: 10.2165/00063030-200923030-00003. Review.

PMID:
19627168
18.

Suppression of premature termination codons as a therapeutic approach.

Keeling KM, Wang D, Conard SE, Bedwell DM.

Crit Rev Biochem Mol Biol. 2012 Sep;47(5):444-63. doi: 10.3109/10409238.2012.694846. Epub 2012 Jun 7. Review.

19.

Splicing regulation as a potential genetic modifier.

Nissim-Rafinia M, Kerem B.

Trends Genet. 2002 Mar;18(3):123-7. Review.

PMID:
11858835
20.

Defects in spliceosomal machinery: a new pathway of leukaemogenesis.

Maciejewski JP, Padgett RA.

Br J Haematol. 2012 Jul;158(2):165-73. doi: 10.1111/j.1365-2141.2012.09158.x. Epub 2012 May 18. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk